Client News
Heidelberg Pharma concludes very successful financial year 2022 and reports on course of business
InflaRx reports full year 2022 financial and operating results
A new prestigious scientific publication for Carbios marks the expansion of its research to other plastics
Mainz Biomed to present at Sidoti Virtual Investor Conference March 22-23
Rentschler Biopharma’s service excellence recognized with CDMO Leadership Awards and Champion status
Newron reports compelling topline results from all patients in Study 014, its Phase II clinical trial evaluating evenamide as add-on therapy for treatment-resistant schizophrenia
Andera Partners co-leads $25m extension round for FIRE1, an Irish medtech developing breakthrough technology for patients with heart failure
Mainz Biomed Announces Partnership with Labor Staber to Expand ColoAlert Commercialization in Germany
ONWARD to publish full year 2022 financial results and host webcast on March 28, 2023